Lodoxamide tromethamine

Modify Date: 2024-01-05 09:59:42

Lodoxamide tromethamine Structure
Lodoxamide tromethamine structure
Common Name Lodoxamide tromethamine
CAS Number 63610-09-3 Molecular Weight 553.90500
Density N/A Boiling Point 827.5ºC at 760 mmHg
Molecular Formula C19H28ClN5O12 Melting Point N/A
MSDS N/A Flash Point 454.3ºC

 Use of Lodoxamide tromethamine


Lodoxamide tromethamine (U 42585 E) is a medication for the treatment of prophylaxis of mast cell-mediated allergic disease.

 Names

Name Lodoxamidetromethamine
Synonym More Synonyms

 Lodoxamide tromethamine Biological Activity

Description Lodoxamide tromethamine (U 42585 E) is a medication for the treatment of prophylaxis of mast cell-mediated allergic disease.
Related Catalog
In Vitro lodoxamide inhibits compound 48/80-induced histamine release and ionophore-induced 45Ca influx with associated histamine release in purified rat peritoneal mast cells[1].
In Vivo Lodoxamide has been demonstrated to have cromolyn-like activity when studied in the rat peritoneal mast cell assay (PCA) model3 and in Ascaris antigen-sensitized rhesus monkeys. When given intravenously, orally, or intrabronchially by aerosol, lodoxamide significantly inhibits the increased respiratory frequency and decreased tidal volume induced by antigen challenge in Ascaris-sensitized. anesthetized rhesus monkeys[1]. Addition of lodoxamide tromethamine to Euro-Collins or University of Wisconsin solution results in a marked decrease in lung reperfusion injury as demonstrated by increased oxygenation, decreased microvascular permeability, and increased compliance[2]. Patients treated with lodoxamide tromethamine demonstrate an improvement in daytime breathing difficulty, cough, sputum production, and sleep[3].
References

[1]. Watt GD, et al. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge. J Allergy Clin Immunol. 1980 Oct;66(4):286-94.

[2]. Barr ML, et al. Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury. J Thorac Cardiovasc Surg. 1998 Mar;115(3):631-6; discussion 636-7.

[3]. Mann JS, et al. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study. J Allergy Clin Immunol. 1985 Jul;76(1):83-90.

 Chemical & Physical Properties

Boiling Point 827.5ºC at 760 mmHg
Molecular Formula C19H28ClN5O12
Molecular Weight 553.90500
Flash Point 454.3ºC
Exact Mass 553.14200
PSA 330.01000
Storage condition -20℃

 Safety Information

Hazard Codes N

 Synonyms

LodoxaMide troMethaMineon
Lodoxamide (tromethamine)
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here





Get all suppliers and price by the below link:

Lodoxamide tromethamine suppliers


Price: ¥561.6/25mg

Reference only. check more Lodoxamide tromethamine price